HEADER OXYGEN TRANSPORT 01-JUL-16 5LFG TITLE X-RAY STRUCTURE OF A NEW FULLY LIGATED CARBOMONOXY FORM OF TREMATOMUS TITLE 2 NEWNESI HEMOGLOBIN (HB1TNCO). COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEMOGLOBIN SUBUNIT ALPHA-1; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: ALPHA-1-GLOBIN,HEMOGLOBIN ALPHA-1 CHAIN; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: HEMOGLOBIN SUBUNIT BETA-1/2; COMPND 7 CHAIN: B, D; COMPND 8 SYNONYM: BETA-1/2-GLOBIN,HEMOGLOBIN BETA-1/2 CHAIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TREMATOMUS NEWNESI; SOURCE 3 ORGANISM_COMMON: DUSKY NOTOTHEN; SOURCE 4 ORGANISM_TAXID: 35730; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: TREMATOMUS NEWNESI; SOURCE 7 ORGANISM_COMMON: DUSKY NOTOTHEN; SOURCE 8 ORGANISM_TAXID: 35730 KEYWDS OXYGEN TRANSPORT, GLOBIN FOLD EXPDTA X-RAY DIFFRACTION AUTHOR L.VITAGLIANO,L.MAZZARELLA,A.MERLINO,A.VERGARA REVDAT 1 09-AUG-17 5LFG 0 JRNL AUTH L.VITAGLIANO,L.MAZZARELLA,A.MERLINO,A.VERGARA JRNL TITL FINE SAMPLING OF THE RT QUATERNARY-STRUCTURE TRANSITION OF A JRNL TITL 2 TETRAMERIC HEMOGLOBIN. JRNL REF CHEMISTRY V. 23 605 2017 JRNL REFN ISSN 1521-3765 JRNL PMID 27808442 JRNL DOI 10.1002/CHEM.201603421 REMARK 2 REMARK 2 RESOLUTION. 1.94 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.5 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 4479 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4461 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 180 REMARK 3 SOLVENT ATOMS : 213 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 ANGLE DISTANCES (A) : NULL REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : NULL REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5LFG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-JUL-16. REMARK 100 THE DEPOSITION ID IS D_1200000652. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUL-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ENRAF-NONIUS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55016 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.940 REMARK 200 RESOLUTION RANGE LOW (A) : 8.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.5 REMARK 200 DATA REDUNDANCY : 2.600 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.94 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : 80.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.40000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALLIZATION TRIALS WERE PERFORMED REMARK 280 UNDER CO ATMOSPHERE. THE DIALYSIS TECHNIQUE WAS USED TO OBTAIN REMARK 280 PROTEIN CRYSTALS: THE PROTEIN, IN A 50 MM TRIS PH 8.0 BUFFER REMARK 280 WITH 2MM DITHIONITE, WITH A CONCENTRATION OF 5 MG X ML-1, WAS REMARK 280 SEPARATED BY THE PRECIPITANT RESERVOIR (2.0 M AMMONIUM SULPHATE, REMARK 280 2 MM DITHIONITE) VIA A DIALYSIS MEMBRANE WITH A 8000 DA CUTOFF. REMARK 280 SINGLE CRYSTALS OF THE CARBOMONOXYLATED HB1TN (HB1TNCO), REMARK 280 SUITABLE FOR X-RAY DIFFRACTION, WERE GROWN IN A WEEK (SIZE 0,2 X REMARK 280 0,2 X 0,1 MM3)., MICRODIALYSIS, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 43.10300 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.62800 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 43.10300 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 43.62800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 12640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -109.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 86.20600 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 12090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -116.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 63.76468 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 107.32694 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH C 355 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN D 50 REMARK 465 ALA D 51 REMARK 465 GLU D 52 REMARK 465 HIS D 146 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 FE HEM D 201 C CMO D 202 1.62 REMARK 500 C CMO B 201 FE HEM B 202 1.82 REMARK 500 C CMO C 201 FE HEM C 202 1.82 REMARK 500 C CMO A 201 FE HEM A 202 1.86 REMARK 500 ND HEM D 201 C CMO D 202 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR A 90 CB - CG - CD2 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG A 140 CD - NE - CZ ANGL. DEV. = 9.1 DEGREES REMARK 500 ARG A 140 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG A 142 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 ARG C 93 CD - NE - CZ ANGL. DEV. = 12.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 49 57.76 -91.33 REMARK 500 ASP A 76 79.46 -156.47 REMARK 500 ASN B 50 157.61 -47.98 REMARK 500 ASP C 48 64.26 62.62 REMARK 500 ASN D 80 39.18 -150.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 202 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 88 NE2 REMARK 620 2 HEM A 202 NA 93.0 REMARK 620 3 HEM A 202 NB 94.7 89.0 REMARK 620 4 HEM A 202 NC 91.1 175.7 89.5 REMARK 620 5 HEM A 202 ND 89.6 90.8 175.7 90.4 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 202 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 92 NE2 REMARK 620 2 HEM B 202 NA 77.9 REMARK 620 3 HEM B 202 NB 85.8 89.5 REMARK 620 4 HEM B 202 NC 98.4 176.3 89.3 REMARK 620 5 HEM B 202 ND 90.2 90.8 175.8 90.1 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM C 202 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS C 88 NE2 REMARK 620 2 HEM C 202 NA 93.1 REMARK 620 3 HEM C 202 NB 90.9 90.7 REMARK 620 4 HEM C 202 NC 90.3 176.6 88.8 REMARK 620 5 HEM C 202 ND 92.2 90.6 176.6 89.7 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM D 201 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 92 NE2 REMARK 620 2 HEM D 201 NA 91.7 REMARK 620 3 HEM D 201 NB 86.7 90.2 REMARK 620 4 HEM D 201 NC 87.5 179.2 90.0 REMARK 620 5 HEM D 201 ND 93.4 90.1 179.7 89.7 REMARK 620 6 CMO D 202 O 173.7 94.1 95.5 86.6 84.4 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CMO A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HEM A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CMO B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HEM B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CMO C 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HEM C 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HEM D 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CMO D 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ACE C 0 and SER C 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1T1N RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CARBOMONOXY HEMOGLOBIN FROM TREMATOMUS NEWNESI DBREF 5LFG A 1 142 UNP P45718 HBA1_TRENE 1 142 DBREF 5LFG B 1 146 UNP P45720 HBB_TRENE 1 146 DBREF 5LFG C 1 142 UNP P45718 HBA1_TRENE 1 142 DBREF 5LFG D 1 146 UNP P45720 HBB_TRENE 1 146 SEQADV 5LFG ACE A 0 UNP P45718 ACETYLATION SEQADV 5LFG ACE C 0 UNP P45718 ACETYLATION SEQRES 1 A 143 ACE SER LEU SER ASP LYS ASP LYS ALA ALA VAL ARG ALA SEQRES 2 A 143 LEU TRP SER LYS ILE GLY LYS SER SER ASP ALA ILE GLY SEQRES 3 A 143 ASN ASP ALA LEU SER ARG MET ILE VAL VAL TYR PRO GLN SEQRES 4 A 143 THR LYS ILE TYR PHE SER HIS TRP PRO ASP VAL THR PRO SEQRES 5 A 143 GLY SER PRO ASN ILE LYS ALA HIS GLY LYS LYS VAL MET SEQRES 6 A 143 GLY GLY ILE ALA LEU ALA VAL SER LYS ILE ASP ASP LEU SEQRES 7 A 143 LYS THR GLY LEU MET GLU LEU SER GLU GLN HIS ALA TYR SEQRES 8 A 143 LYS LEU ARG VAL ASP PRO SER ASN PHE LYS ILE LEU ASN SEQRES 9 A 143 HIS CYS ILE LEU VAL VAL ILE SER THR MET PHE PRO LYS SEQRES 10 A 143 GLU PHE THR PRO GLU ALA HIS VAL SER LEU ASP LYS PHE SEQRES 11 A 143 LEU SER GLY VAL ALA LEU ALA LEU ALA GLU ARG TYR ARG SEQRES 1 B 146 VAL GLU TRP THR ASP LYS GLU ARG SER ILE ILE SER ASP SEQRES 2 B 146 ILE PHE SER HIS MET ASP TYR ASP ASP ILE GLY PRO LYS SEQRES 3 B 146 ALA LEU SER ARG CYS LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 B 146 ARG TYR PHE SER GLY PHE GLY ASN LEU TYR ASN ALA GLU SEQRES 5 B 146 GLY ILE MET SER ASN ALA ASN VAL ALA ALA HIS GLY ILE SEQRES 6 B 146 LYS VAL LEU HIS GLY LEU ASP ARG GLY MET LYS ASN MET SEQRES 7 B 146 ASP ASN ILE ALA ASP ALA TYR THR ASP LEU SER THR LEU SEQRES 8 B 146 HIS SER GLU LYS LEU HIS VAL ASP PRO ASP ASN PHE LYS SEQRES 9 B 146 LEU LEU SER ASP CYS ILE THR ILE VAL LEU ALA ALA LYS SEQRES 10 B 146 MET GLY HIS ALA PHE THR ALA GLU THR GLN GLY ALA PHE SEQRES 11 B 146 GLN LYS PHE LEU ALA ALA VAL VAL SER ALA LEU GLY LYS SEQRES 12 B 146 GLN TYR HIS SEQRES 1 C 143 ACE SER LEU SER ASP LYS ASP LYS ALA ALA VAL ARG ALA SEQRES 2 C 143 LEU TRP SER LYS ILE GLY LYS SER SER ASP ALA ILE GLY SEQRES 3 C 143 ASN ASP ALA LEU SER ARG MET ILE VAL VAL TYR PRO GLN SEQRES 4 C 143 THR LYS ILE TYR PHE SER HIS TRP PRO ASP VAL THR PRO SEQRES 5 C 143 GLY SER PRO ASN ILE LYS ALA HIS GLY LYS LYS VAL MET SEQRES 6 C 143 GLY GLY ILE ALA LEU ALA VAL SER LYS ILE ASP ASP LEU SEQRES 7 C 143 LYS THR GLY LEU MET GLU LEU SER GLU GLN HIS ALA TYR SEQRES 8 C 143 LYS LEU ARG VAL ASP PRO SER ASN PHE LYS ILE LEU ASN SEQRES 9 C 143 HIS CYS ILE LEU VAL VAL ILE SER THR MET PHE PRO LYS SEQRES 10 C 143 GLU PHE THR PRO GLU ALA HIS VAL SER LEU ASP LYS PHE SEQRES 11 C 143 LEU SER GLY VAL ALA LEU ALA LEU ALA GLU ARG TYR ARG SEQRES 1 D 146 VAL GLU TRP THR ASP LYS GLU ARG SER ILE ILE SER ASP SEQRES 2 D 146 ILE PHE SER HIS MET ASP TYR ASP ASP ILE GLY PRO LYS SEQRES 3 D 146 ALA LEU SER ARG CYS LEU VAL VAL TYR PRO TRP THR GLN SEQRES 4 D 146 ARG TYR PHE SER GLY PHE GLY ASN LEU TYR ASN ALA GLU SEQRES 5 D 146 GLY ILE MET SER ASN ALA ASN VAL ALA ALA HIS GLY ILE SEQRES 6 D 146 LYS VAL LEU HIS GLY LEU ASP ARG GLY MET LYS ASN MET SEQRES 7 D 146 ASP ASN ILE ALA ASP ALA TYR THR ASP LEU SER THR LEU SEQRES 8 D 146 HIS SER GLU LYS LEU HIS VAL ASP PRO ASP ASN PHE LYS SEQRES 9 D 146 LEU LEU SER ASP CYS ILE THR ILE VAL LEU ALA ALA LYS SEQRES 10 D 146 MET GLY HIS ALA PHE THR ALA GLU THR GLN GLY ALA PHE SEQRES 11 D 146 GLN LYS PHE LEU ALA ALA VAL VAL SER ALA LEU GLY LYS SEQRES 12 D 146 GLN TYR HIS HET ACE A 0 3 HET ACE C 0 3 HET CMO A 201 2 HET HEM A 202 43 HET CMO B 201 2 HET HEM B 202 43 HET CMO C 201 2 HET HEM C 202 43 HET HEM D 201 43 HET CMO D 202 2 HETNAM ACE ACETYL GROUP HETNAM CMO CARBON MONOXIDE HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETSYN HEM HEME FORMUL 1 ACE 2(C2 H4 O) FORMUL 5 CMO 4(C O) FORMUL 6 HEM 4(C34 H32 FE N4 O4) FORMUL 13 HOH *213(H2 O) HELIX 1 AA1 SER A 3 GLY A 18 1 16 HELIX 2 AA2 SER A 20 TYR A 36 1 17 HELIX 3 AA3 PRO A 37 SER A 44 5 8 HELIX 4 AA4 SER A 53 LYS A 73 1 21 HELIX 5 AA5 ASP A 76 LYS A 91 1 16 HELIX 6 AA6 ASP A 95 SER A 97 5 3 HELIX 7 AA7 ASN A 98 PHE A 114 1 17 HELIX 8 AA8 THR A 119 ALA A 138 1 20 HELIX 9 AA9 THR B 4 HIS B 17 1 14 HELIX 10 AB1 ASP B 19 TYR B 35 1 17 HELIX 11 AB2 PRO B 36 GLY B 46 5 11 HELIX 12 AB3 ASN B 57 ASN B 77 1 21 HELIX 13 AB4 ASN B 80 TYR B 85 1 6 HELIX 14 AB5 TYR B 85 LYS B 95 1 11 HELIX 15 AB6 PRO B 100 GLY B 119 1 20 HELIX 16 AB7 HIS B 120 PHE B 122 5 3 HELIX 17 AB8 THR B 123 GLY B 142 1 20 HELIX 18 AB9 SER C 3 GLY C 18 1 16 HELIX 19 AC1 SER C 20 TYR C 36 1 17 HELIX 20 AC2 THR C 39 SER C 44 1 6 HELIX 21 AC3 SER C 53 LYS C 73 1 21 HELIX 22 AC4 ASP C 76 LYS C 91 1 16 HELIX 23 AC5 SER C 97 PHE C 114 1 18 HELIX 24 AC6 THR C 119 GLU C 139 1 21 HELIX 25 AC7 ARG C 140 ARG C 142 5 3 HELIX 26 AC8 THR D 4 HIS D 17 1 14 HELIX 27 AC9 ASP D 19 TYR D 35 1 17 HELIX 28 AD1 PRO D 36 ARG D 40 5 5 HELIX 29 AD2 GLY D 53 SER D 56 5 4 HELIX 30 AD3 ASN D 57 LYS D 76 1 20 HELIX 31 AD4 ASN D 77 ASP D 79 5 3 HELIX 32 AD5 ASN D 80 TYR D 85 1 6 HELIX 33 AD6 TYR D 85 LYS D 95 1 11 HELIX 34 AD7 PRO D 100 GLY D 119 1 20 HELIX 35 AD8 HIS D 120 PHE D 122 5 3 HELIX 36 AD9 THR D 123 GLY D 142 1 20 LINK C ACE A 0 N SER A 1 1555 1555 1.31 LINK NE2 HIS A 88 FE HEM A 202 1555 1555 2.13 LINK NE2 HIS B 92 FE HEM B 202 1555 1555 2.13 LINK C ACE C 0 N SER C 1 1555 1555 1.32 LINK NE2 HIS C 88 FE HEM C 202 1555 1555 2.17 LINK NE2 HIS D 92 FE HEM D 201 1555 1555 2.06 LINK FE HEM D 201 O CMO D 202 1555 1555 2.62 SITE 1 AC1 3 HIS A 59 VAL A 63 HEM A 202 SITE 1 AC2 17 TYR A 42 PHE A 43 HIS A 45 TRP A 46 SITE 2 AC2 17 HIS A 59 LYS A 62 VAL A 63 LEU A 84 SITE 3 AC2 17 HIS A 88 LEU A 92 VAL A 94 ASN A 98 SITE 4 AC2 17 LEU A 102 ASN A 103 LEU A 137 CMO A 201 SITE 5 AC2 17 HOH A 316 SITE 1 AC3 3 HIS B 63 VAL B 67 HEM B 202 SITE 1 AC4 13 TYR B 41 PHE B 45 HIS B 63 LYS B 66 SITE 2 AC4 13 VAL B 67 LEU B 91 HIS B 92 LEU B 96 SITE 3 AC4 13 VAL B 98 ASN B 102 PHE B 103 LEU B 141 SITE 4 AC4 13 CMO B 201 SITE 1 AC5 3 HIS C 59 VAL C 63 HEM C 202 SITE 1 AC6 18 ASN B 47 TYR C 42 HIS C 45 TRP C 46 SITE 2 AC6 18 HIS C 59 LYS C 62 VAL C 63 LEU C 84 SITE 3 AC6 18 GLN C 87 HIS C 88 LYS C 91 LEU C 92 SITE 4 AC6 18 VAL C 94 ASN C 98 PHE C 99 LEU C 102 SITE 5 AC6 18 LEU C 137 CMO C 201 SITE 1 AC7 12 THR D 38 TYR D 41 PHE D 42 PHE D 45 SITE 2 AC7 12 HIS D 63 LEU D 88 HIS D 92 LEU D 96 SITE 3 AC7 12 ASN D 102 PHE D 103 LEU D 141 CMO D 202 SITE 1 AC8 3 VAL D 67 HIS D 92 HEM D 201 SITE 1 AC9 5 LEU C 2 SER C 3 LYS C 128 GLU C 139 SITE 2 AC9 5 ARG C 142 CRYST1 86.206 87.256 109.648 90.00 101.81 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011600 0.000000 0.002425 0.00000 SCALE2 0.000000 0.011461 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009317 0.00000 HETATM 1 C ACE A 0 38.889 -15.951 5.201 1.00 33.16 C HETATM 2 O ACE A 0 37.852 -15.769 4.422 1.00 37.53 O HETATM 3 CH3 ACE A 0 39.769 -14.920 5.667 1.00 26.05 C